ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Eculizumab Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-14S8608
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Eculizumab Market Insights Forecast to 2028
BUY CHAPTERS

Global Eculizumab Market Research Report 2024

Code: QYRE-Auto-14S8608
Report
October 2024
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alexion Pharmaceuticals
Amgen Inc
Samsung Bioepis

Eculizumab Market

Eculizumab is a monoclonal antibody that inhibits complement protein C5, blocking the formation of the membrane attack complex (MAC) and preventing immune-mediated cell destruction. It is primarily used to treat rare diseases such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD).
The global Eculizumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Eculizumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eculizumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eculizumab include Alexion Pharmaceuticals, Amgen, Samsung Bioepis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Eculizumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eculizumab.
The Eculizumab market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Eculizumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eculizumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Eculizumab Market Report

Report Metric Details
Report Name Eculizumab Market
Segment by Type
Segment by Application
  • PNH
  • aHUS
  • gMG
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alexion Pharmaceuticals, Amgen, Samsung Bioepis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Eculizumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Eculizumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Eculizumab Market report?

Ans: The main players in the Eculizumab Market are Alexion Pharmaceuticals, Amgen, Samsung Bioepis

What are the Application segmentation covered in the Eculizumab Market report?

Ans: The Applications covered in the Eculizumab Market report are PNH, aHUS, gMG, Others

What are the Type segmentation covered in the Eculizumab Market report?

Ans: The Types covered in the Eculizumab Market report are Original Drug, Biosimilar

Recommended Reports

Rare Disease Treatment

Antibody Drug Markets

Blood Disorders Drugs

1 Eculizumab Market Overview
1.1 Product Definition
1.2 Eculizumab by Type
1.2.1 Global Eculizumab Market Value Comparison by Type (2024-2030)
1.2.2 Original Drug
1.2.3 Biosimilar
1.3 Eculizumab by Application
1.3.1 Global Eculizumab Market Value by Application (2024-2030)
1.3.2 PNH
1.3.3 aHUS
1.3.4 gMG
1.3.5 Others
1.4 Global Eculizumab Market Size Estimates and Forecasts
1.4.1 Global Eculizumab Revenue 2019-2030
1.4.2 Global Eculizumab Sales 2019-2030
1.4.3 Global Eculizumab Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eculizumab Market Competition by Manufacturers
2.1 Global Eculizumab Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eculizumab Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eculizumab Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Eculizumab, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eculizumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eculizumab, Product Type & Application
2.7 Global Key Manufacturers of Eculizumab, Date of Enter into This Industry
2.8 Global Eculizumab Market Competitive Situation and Trends
2.8.1 Global Eculizumab Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Eculizumab Players Market Share by Revenue
2.8.3 Global Eculizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Eculizumab Market Scenario by Region
3.1 Global Eculizumab Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eculizumab Sales by Region: 2019-2030
3.2.1 Global Eculizumab Sales by Region: 2019-2024
3.2.2 Global Eculizumab Sales by Region: 2025-2030
3.3 Global Eculizumab Revenue by Region: 2019-2030
3.3.1 Global Eculizumab Revenue by Region: 2019-2024
3.3.2 Global Eculizumab Revenue by Region: 2025-2030
3.4 North America Eculizumab Market Facts & Figures by Country
3.4.1 North America Eculizumab Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eculizumab Sales by Country (2019-2030)
3.4.3 North America Eculizumab Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eculizumab Market Facts & Figures by Country
3.5.1 Europe Eculizumab Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eculizumab Sales by Country (2019-2030)
3.5.3 Europe Eculizumab Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eculizumab Market Facts & Figures by Region
3.6.1 Asia Pacific Eculizumab Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eculizumab Sales by Region (2019-2030)
3.6.3 Asia Pacific Eculizumab Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Eculizumab Market Facts & Figures by Country
3.7.1 Latin America Eculizumab Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eculizumab Sales by Country (2019-2030)
3.7.3 Latin America Eculizumab Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Eculizumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Eculizumab Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eculizumab Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eculizumab Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eculizumab Sales by Type (2019-2030)
4.1.1 Global Eculizumab Sales by Type (2019-2024)
4.1.2 Global Eculizumab Sales by Type (2025-2030)
4.1.3 Global Eculizumab Sales Market Share by Type (2019-2030)
4.2 Global Eculizumab Revenue by Type (2019-2030)
4.2.1 Global Eculizumab Revenue by Type (2019-2024)
4.2.2 Global Eculizumab Revenue by Type (2025-2030)
4.2.3 Global Eculizumab Revenue Market Share by Type (2019-2030)
4.3 Global Eculizumab Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eculizumab Sales by Application (2019-2030)
5.1.1 Global Eculizumab Sales by Application (2019-2024)
5.1.2 Global Eculizumab Sales by Application (2025-2030)
5.1.3 Global Eculizumab Sales Market Share by Application (2019-2030)
5.2 Global Eculizumab Revenue by Application (2019-2030)
5.2.1 Global Eculizumab Revenue by Application (2019-2024)
5.2.2 Global Eculizumab Revenue by Application (2025-2030)
5.2.3 Global Eculizumab Revenue Market Share by Application (2019-2030)
5.3 Global Eculizumab Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alexion Pharmaceuticals
6.1.1 Alexion Pharmaceuticals Company Information
6.1.2 Alexion Pharmaceuticals Description and Business Overview
6.1.3 Alexion Pharmaceuticals Eculizumab Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alexion Pharmaceuticals Eculizumab Product Portfolio
6.1.5 Alexion Pharmaceuticals Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Eculizumab Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amgen Eculizumab Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Samsung Bioepis
6.3.1 Samsung Bioepis Company Information
6.3.2 Samsung Bioepis Description and Business Overview
6.3.3 Samsung Bioepis Eculizumab Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Samsung Bioepis Eculizumab Product Portfolio
6.3.5 Samsung Bioepis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eculizumab Industry Chain Analysis
7.2 Eculizumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eculizumab Production Mode & Process
7.4 Eculizumab Sales and Marketing
7.4.1 Eculizumab Sales Channels
7.4.2 Eculizumab Distributors
7.5 Eculizumab Customers
8 Eculizumab Market Dynamics
8.1 Eculizumab Industry Trends
8.2 Eculizumab Market Drivers
8.3 Eculizumab Market Challenges
8.4 Eculizumab Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Alexion Pharmaceuticals
Amgen Inc
Samsung Bioepis
List of Tables
 Table 1. Global Eculizumab Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Eculizumab Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Eculizumab Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Eculizumab Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Eculizumab Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Eculizumab Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Eculizumab Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Eculizumab Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Eculizumab, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Eculizumab, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Eculizumab, Product Type & Application
 Table 12. Global Key Manufacturers of Eculizumab, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Eculizumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eculizumab as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Eculizumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Eculizumab Sales by Region (2019-2024) & (K Units)
 Table 18. Global Eculizumab Sales Market Share by Region (2019-2024)
 Table 19. Global Eculizumab Sales by Region (2025-2030) & (K Units)
 Table 20. Global Eculizumab Sales Market Share by Region (2025-2030)
 Table 21. Global Eculizumab Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Eculizumab Revenue Market Share by Region (2019-2024)
 Table 23. Global Eculizumab Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Eculizumab Revenue Market Share by Region (2025-2030)
 Table 25. North America Eculizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Eculizumab Sales by Country (2019-2024) & (K Units)
 Table 27. North America Eculizumab Sales by Country (2025-2030) & (K Units)
 Table 28. North America Eculizumab Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Eculizumab Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Eculizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Eculizumab Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Eculizumab Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Eculizumab Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Eculizumab Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Eculizumab Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Eculizumab Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Eculizumab Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Eculizumab Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Eculizumab Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Eculizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Eculizumab Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Eculizumab Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Eculizumab Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Eculizumab Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Eculizumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Eculizumab Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Eculizumab Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Eculizumab Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Eculizumab Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Eculizumab Sales (K Units) by Type (2019-2024)
 Table 51. Global Eculizumab Sales (K Units) by Type (2025-2030)
 Table 52. Global Eculizumab Sales Market Share by Type (2019-2024)
 Table 53. Global Eculizumab Sales Market Share by Type (2025-2030)
 Table 54. Global Eculizumab Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Eculizumab Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Eculizumab Revenue Market Share by Type (2019-2024)
 Table 57. Global Eculizumab Revenue Market Share by Type (2025-2030)
 Table 58. Global Eculizumab Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Eculizumab Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Eculizumab Sales (K Units) by Application (2019-2024)
 Table 61. Global Eculizumab Sales (K Units) by Application (2025-2030)
 Table 62. Global Eculizumab Sales Market Share by Application (2019-2024)
 Table 63. Global Eculizumab Sales Market Share by Application (2025-2030)
 Table 64. Global Eculizumab Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Eculizumab Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Eculizumab Revenue Market Share by Application (2019-2024)
 Table 67. Global Eculizumab Revenue Market Share by Application (2025-2030)
 Table 68. Global Eculizumab Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Eculizumab Price (US$/Unit) by Application (2025-2030)
 Table 70. Alexion Pharmaceuticals Company Information
 Table 71. Alexion Pharmaceuticals Description and Business Overview
 Table 72. Alexion Pharmaceuticals Eculizumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Alexion Pharmaceuticals Eculizumab Product
 Table 74. Alexion Pharmaceuticals Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Eculizumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Amgen Eculizumab Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Samsung Bioepis Company Information
 Table 81. Samsung Bioepis Description and Business Overview
 Table 82. Samsung Bioepis Eculizumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Samsung Bioepis Eculizumab Product
 Table 84. Samsung Bioepis Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Eculizumab Distributors List
 Table 88. Eculizumab Customers List
 Table 89. Eculizumab Market Trends
 Table 90. Eculizumab Market Drivers
 Table 91. Eculizumab Market Challenges
 Table 92. Eculizumab Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Eculizumab
 Figure 2. Global Eculizumab Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Eculizumab Market Share by Type: 2023 & 2030
 Figure 4. Original Drug Product Picture
 Figure 5. Biosimilar Product Picture
 Figure 6. Global Eculizumab Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Eculizumab Market Share by Application: 2023 & 2030
 Figure 8. PNH
 Figure 9. aHUS
 Figure 10. gMG
 Figure 11. Others
 Figure 12. Global Eculizumab Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Eculizumab Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Eculizumab Sales (2019-2030) & (K Units)
 Figure 15. Global Eculizumab Average Price (US$/Unit) & (2019-2030)
 Figure 16. Eculizumab Report Years Considered
 Figure 17. Eculizumab Sales Share by Manufacturers in 2023
 Figure 18. Global Eculizumab Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Eculizumab Players: Market Share by Revenue in Eculizumab in 2023
 Figure 20. Eculizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Eculizumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Eculizumab Sales Market Share by Country (2019-2030)
 Figure 23. North America Eculizumab Revenue Market Share by Country (2019-2030)
 Figure 24. United States Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Eculizumab Sales Market Share by Country (2019-2030)
 Figure 27. Europe Eculizumab Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Eculizumab Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Eculizumab Revenue Market Share by Region (2019-2030)
 Figure 35. China Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Eculizumab Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Eculizumab Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Eculizumab Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Eculizumab Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Eculizumab by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Eculizumab by Type (2019-2030)
 Figure 54. Global Eculizumab Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Eculizumab by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Eculizumab by Application (2019-2030)
 Figure 57. Global Eculizumab Price (US$/Unit) by Application (2019-2030)
 Figure 58. Eculizumab Value Chain
 Figure 59. Eculizumab Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Complement C5 Recombinant Monoclonal Antibody Market Research Report 2024
Global Treatment of PNH Market Research Report 2024
Global Drugs for PNH Market Research Report 2024
Global Complement Inhibitors Market Research Report 2024
Global Complement Protein C3 Inhibitors Market Research Report 2024
Global Tocilizumab Drugs Market Research Report 2024
Global Pegcetacoplan Injection Market Research Report 2024
C5 Complement Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alirocumab Market Research Report 2024
Global Dupilumab Injection Market Research Report 2024
Global Emicizumab Injection Market Research Report 2024
Global Pertuzumab Market Research Report 2025
Global Ranibizumab Drugs and Biosimilars Market Research Report 2024
Global Broluzumab Biosimilars Market Research Report 2025
Soliris Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Soliris Market Insights Forecast to 2030
Global Tocilizumab Market Research Report 2024
Global Complement C4 Antibody Market Research Report 2024
Global Anti CD25 Monoclonal Antibody Market Research Report 2024
Global Paroxysmal Nocturnal Hemoglobinuria PNH Treatment Market Research Report 2024

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions